JP2024517710A5 - - Google Patents

Info

Publication number
JP2024517710A5
JP2024517710A5 JP2023565854A JP2023565854A JP2024517710A5 JP 2024517710 A5 JP2024517710 A5 JP 2024517710A5 JP 2023565854 A JP2023565854 A JP 2023565854A JP 2023565854 A JP2023565854 A JP 2023565854A JP 2024517710 A5 JP2024517710 A5 JP 2024517710A5
Authority
JP
Japan
Prior art keywords
targeted peptide
modified
modified aav
capsid protein
aav according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023565854A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517710A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/026518 external-priority patent/WO2022232257A1/en
Publication of JP2024517710A publication Critical patent/JP2024517710A/ja
Publication of JP2024517710A5 publication Critical patent/JP2024517710A5/ja
Pending legal-status Critical Current

Links

JP2023565854A 2021-04-27 2022-04-27 蝸牛に形質導入するためのアデノ随伴ウイルスベクター Pending JP2024517710A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163180394P 2021-04-27 2021-04-27
US63/180,394 2021-04-27
PCT/US2022/026518 WO2022232257A1 (en) 2021-04-27 2022-04-27 Adeno-associated viral vectors for transduction of cochlea

Publications (2)

Publication Number Publication Date
JP2024517710A JP2024517710A (ja) 2024-04-23
JP2024517710A5 true JP2024517710A5 (cg-RX-API-DMAC7.html) 2025-04-21

Family

ID=83847287

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565854A Pending JP2024517710A (ja) 2021-04-27 2022-04-27 蝸牛に形質導入するためのアデノ随伴ウイルスベクター

Country Status (7)

Country Link
US (1) US20240197920A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330413A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024517710A (cg-RX-API-DMAC7.html)
KR (1) KR20240004536A (cg-RX-API-DMAC7.html)
AU (1) AU2022264006A1 (cg-RX-API-DMAC7.html)
CA (1) CA3216591A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022232257A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL325122A (en) 2018-02-22 2026-02-01 Akouos Inc Compositions and methods for treating non-age-related hearing impairment in humans
CN121816425A (zh) * 2023-09-11 2026-04-07 学校法人顺天堂 能够感染内耳的aav变体
AR134407A1 (es) * 2023-11-15 2026-01-14 Genzyme Corp Métodos de tratamiento de la enfermedad de gaucher y de la enfermedad de parkinson gba
CN122206466A (zh) * 2023-11-15 2026-06-12 建新公司 治疗神经变性障碍的方法
WO2025170984A1 (en) * 2024-02-05 2025-08-14 The Children's Hospital Of Philadelphia Cell-type-specific control of gene expression in auditory hair cells
WO2026052039A1 (en) * 2024-09-06 2026-03-12 Sichuan Real & Best Biotech Co., Ltd. Engineered adeno-associated virus capsid protein and the use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7430652B2 (ja) * 2018-03-05 2024-02-13 ザ チルドレンズ メディカル センター コーポレーション 蝸牛および前庭細胞に核酸を送達するための組成物および方法
US12534739B2 (en) * 2018-10-11 2026-01-27 Decibel Therapeutics, Inc. AAV1 vectors and uses thereof for treatment of otic indications
JP7713130B2 (ja) * 2019-09-30 2025-07-25 イーライ リリー アンド カンパニー 遺伝性難聴の処置のためのアデノ随伴ウイルス(aav)システム
AU2020366531A1 (en) * 2019-10-18 2022-05-26 Research Institute At Nationwide Children's Hospital Gene therapy targeting cochlear cells
EP4165194A2 (en) * 2020-05-13 2023-04-19 Akouos, Inc. Compositions and methods for treating kcnq4-associated hearing loss

Similar Documents

Publication Publication Date Title
JP2022526018A5 (cg-RX-API-DMAC7.html)
JP2024540221A (ja) Aavカプシドバリアント及びその使用
CN107207556B (zh) 调节性多核苷酸
JP2022501040A5 (cg-RX-API-DMAC7.html)
JP2025179046A5 (cg-RX-API-DMAC7.html)
JP2022141670A5 (cg-RX-API-DMAC7.html)
JP2022500066A5 (cg-RX-API-DMAC7.html)
JP2023515072A5 (cg-RX-API-DMAC7.html)
JP2021513863A5 (cg-RX-API-DMAC7.html)
Lustig et al. Cochlear gene therapy
JP2020526514A5 (cg-RX-API-DMAC7.html)
JP2022519623A5 (cg-RX-API-DMAC7.html)
JP2024515459A5 (cg-RX-API-DMAC7.html)
JP2022553573A5 (cg-RX-API-DMAC7.html)
JP2023534037A5 (cg-RX-API-DMAC7.html)
JP2021500922A5 (cg-RX-API-DMAC7.html)
AU2019299861A1 (en) Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
JP2020105169A5 (cg-RX-API-DMAC7.html)
CN114848850A (zh) Rs1基因在制备xlrs治疗剂中的应用及治疗剂
WO2021247995A2 (en) Compositions and methods of treating neuropathic pain
JP2025516583A5 (cg-RX-API-DMAC7.html)
JP2023545229A5 (cg-RX-API-DMAC7.html)
JP2020527167A5 (cg-RX-API-DMAC7.html)
JP2022549892A5 (cg-RX-API-DMAC7.html)
JP2022553375A5 (cg-RX-API-DMAC7.html)